{"id":"W2093322643","doi":"10.1186/1476-4598-6-67","title":"Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia","year":2007,"lang":"en","type":"article","venue":"Molecular Cancer","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Stem Cell Network; Kenneth T. and Eileen L. Norris Foundation","keywords":"Nilotinib; Imatinib; Leukemia; Cancer research; Chronic myelogenous leukemia; Imatinib mesylate; Tyrosine-kinase inhibitor; Philadelphia chromosome; Acute lymphocytic leukemia; Tyrosine kinase; Medicine; Biology; Immunology; Internal medicine; Myeloid leukemia; Cancer; Chromosomal translocation; Lymphoblastic Leukemia; Receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001392242,0.0002783259,0.0005024389,0.000217331,0.00002185256,0.00000559198,0.00009567127,0.0001405143,0.0001851679],"category_scores_gemma":[0.00002942022,0.0002421642,0.000160768,0.0003028745,0.00007326483,0.00006250635,0.00003641756,0.0001060492,0.00002435115],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008790135,"about_ca_system_score_gemma":0.001465074,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004609425,"about_ca_topic_score_gemma":0.0008310459,"domain_scores_codex":[0.9982561,0.00003017003,0.0004553195,0.0004015007,0.0003666689,0.0004902817],"domain_scores_gemma":[0.9990686,0.00005114997,0.0001182629,0.0005049333,0.00007256424,0.0001845107],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003763089,0.002594581,0.04219218,0.0006762603,0.001738659,0.005405817,0.003609215,0.05745341,0.7811646,0.002312025,0.0006683466,0.09842178],"study_design_scores_gemma":[0.02351988,0.001070974,0.009844801,0.0004629073,0.0004339576,0.00008526498,0.0001559083,0.01071229,0.950576,0.0003697832,0.002289917,0.0004782909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879372,0.00251684,0.002400865,0.00008410504,0.0001037613,0.0006780867,0.00002698315,0.00004877418,0.006203449],"genre_scores_gemma":[0.9954262,0.0002837131,0.001117665,0.0002733383,0.0000563609,0.0001068476,0.00002869085,0.00006150212,0.002645733],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1694114,"threshold_uncertainty_score":0.995015,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01972228297517697,"score_gpt":0.2880412356463142,"score_spread":0.2683189526711372,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}